MP:0000952 | abnormal CNS glia | "anomalous structure, number or composition of non-neuronal cells of the central nervous system that form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0003009 | abnormal cytokine secretion | "impairment or increase of the cellular release of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells " [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, smb:Susan M. Bello , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0003156 | abnormal lymphocyte migration/homing | "altered ability of blood lymphocytes to bind to high endothelial venules (HEV), tether and roll along the luminal aspects of HEV, and migrate into the lymph nodes" [acv:Alicia C. Valenzuela, Mouse Genome Informatics Curator, J:92231] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0005399 | increased susceptibility to fungal infection | "greater likelihood that an organism will develop ill effects from infection by a yeast or mold, or from components of, or toxins produced by, these organisms" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0005547 | abnormal Muller cell morphology | "anomalous structure of the elongated neuroglial cells that traverse all the layers of the retina and that act as supporting elements" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0005617 | increased susceptibility to type IV hypersensitivity reaction | "greater likelihood of developing an antigen-elicited cellular immune reaction that results in tissue damage, but does not require Ab participation; the response is seen at the area of contact " [Pathology:ISBN 0-397-51047-0, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008560 | increased tumor necrosis factor secretion | "increase in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008566 | increased interferon-gamma secretion | "increase in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008660 | increased interleukin-10 secretion | "increase in the production or release of a cytokine produced by a variety of cell types, including T-cells, monocytes, dendritic cells and epithelial cells that exerts a variety of effects on immunoregulation and inflammation" [MESH:D12.644.276.374.465.510] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008663 | increased interleukin-12 secretion | "increase in the production or release of a heterodimeric cytokine that plays a role in innate and adaptive immune responses; it is produced by dendritic cells, macrophages and a variety of other immune cells and plays a role in the stimulation of interferon-gamma production by T-cells and natural killer cells" [MESH:D12.644.276.374.465.512] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008687 | increased interleukin-2 secretion | "increase in the production or release of a soluble substance elaborated by antigen- or mitogen-stimulated T-cells which induces DNA synthesis in naive lymphocytes" [MESH:D12.644.276.374.465.502] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008699 | increased interleukin-4 secretion | "increase in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008702 | increased interleukin-5 secretion | "increase in the production or release of a cytokine that promotes differentiation and activation of eosinophils; it also triggers activated B-cells to differentiate into immunoglobulin-secreting cells" [MESH:D12.644.276.374.465.505] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|
MP:0008722 | abnormal chemokine secretion | "anomaly in the production or cellular release of any of the class of pro-inflammatory cytokines that attract and activate leukocytes" [MESH:D12.644.276.374.200] |
Show
Allelic Composition: Nr3c1tm1Gsc/Nr3c1tm1Gsc Genetic Background: involves: 129P2/OlaHsd * 129/Sv
|